NCT00244309View on ClinicalTrials.gov

Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Prostate Cancer
Interventions
DRUG

tamsulosin and/or dutasteride

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER

NCT00244309 - Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer | Biotech Hunter | Biotech Hunter